We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
Cap. Flow
-$39M
Cap. Flow %
-8.97%
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$4.08M
2
UI icon
Ubiquiti
UI
+$3.96M
3
CRM icon
Salesforce
CRM
+$3.69M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.57M
5
GMED icon
Globus Medical
GMED
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Technology 17.18%
3 Consumer Discretionary 15.3%
4 Financials 9.77%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SM icon
51
SM Energy
SM
$9.08B
$2.74M 0.63%
+105,000
New +$3.15M
PLAB icon
52
Photronics
PLAB
$1.64B
$2.73M 0.63%
+84,000
New +$3.55M
FSLY icon
53
Fastly Inc
FSLY
$3.75B
$2.7M 0.62%
147,000
+42,000
+40% +$913K
BIP icon
54
Brookfield Infrastructure Partners
BIP
$16.4B
$2.68M 0.62%
73,500
-10,500
-13% -$392K
BKE icon
55
Buckle
BKE
$2.06B
$2.66M 0.61%
63,000
+21,000
+50% +$1.04M
AAL icon
56
American Airlines Group
AAL
$8.41B
$2.66M 0.61%
147,000
-63,000
-30% -$843K
GCT icon
57
GigaCloud Technology
GCT
$1.84B
$2.65M 0.61%
84,000
+52,500
+167% +$2.07M
FIVE icon
58
Five Below
FIVE
$13.1B
$2.64M 0.61%
14,700
+2,100
+17% +$452K
SRPT icon
59
Sarepta Therapeutics
SRPT
$2.09B
$2.64M 0.61%
+147,000
New +$2.78M
MTDR icon
60
Matador Resources
MTDR
$7.14B
$2.61M 0.6%
+52,500
New +$2.98M
AAP icon
61
Advance Auto Parts
AAP
$2.53B
$2.61M 0.6%
42,000
ANIP icon
62
ANI Pharmaceuticals
ANIP
$1.69B
$2.61M 0.6%
31,500
-21,000
-40% -$1.68M
CVS icon
63
CVS Health
CVS
$117B
$2.61M 0.6%
25,200
-16,800
-40% -$1.5M
DVN icon
64
Devon Energy
DVN
$53.3B
$2.6M 0.6%
63,000
+21,000
+50% +$973K
CRI icon
65
Carter's
CRI
$1.07B
$2.59M 0.6%
63,000
+42,000
+200% +$1.59M
FANG icon
66
Diamondback Energy
FANG
$54.5B
$2.58M 0.6%
14,700
+4,200
+40% +$815K
APTV icon
67
Aptiv
APTV
$9B
$2.58M 0.59%
42,000
+4,200
+11% +$257K
PTCT icon
68
PTC Therapeutics
PTCT
$5.64B
$2.57M 0.59%
+31,500
New +$2.27M
ADM icon
69
Archer Daniels Midland
ADM
$41B
$2.57M 0.59%
33,600
-8,400
-20% -$639K
CQP icon
70
Cheniere Energy
CQP
$31.8B
$2.56M 0.59%
42,000
NTRS icon
71
Northern Trust
NTRS
$32.3B
$2.56M 0.59%
14,700
BKU icon
72
Bankunited
BKU
$3.17B
$2.54M 0.59%
52,500
+21,000
+67% +$988K
RUN icon
73
Sunrun
RUN
$1.99B
$2.53M 0.58%
189,000
+84,000
+80% +$1.13M
SHLS icon
74
Shoals Technologies Group
SHLS
$1.15B
$2.49M 0.57%
252,000
-168,000
-40% -$1.53M
IPGP icon
75
IPG Photonics
IPGP
$3.27B
$2.46M 0.57%
+21,000
New +$2.41M

Similar funds

Hussman Strategic Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.

  • Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
  • Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
  • Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
  • Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
  • Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
  • Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
  • Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.